Data mining of micrornas in breast carcinogenesis which may be a potential target for cancer prevention

被引:0
|
作者
Kang, Jin-Wook [1 ,2 ]
Kim, Min-Ji [1 ,2 ]
Baek, Hyun-Ah [3 ]
Lee, Jeong-Sang [1 ,2 ,3 ]
机构
[1] Jeonju Univ, Mol Mech Funct Foods Lab, Jeonju 55069, South Korea
[2] Jeonju Univ, Coll Med Sci, Dept Funct Food & Biotechnol, Jeonju 55069, South Korea
[3] Jeonju Univ, Food Ind Res Inst, Jeonju 55069, South Korea
基金
新加坡国家研究基金会;
关键词
microRNA; breast cancer; data mining; chemoprevention; target; ANIMAL DEVELOPMENT; EXPRESSION; BIOMARKERS; MIRNAS;
D O I
10.1007/s10068-016-0111-x
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
The microRNAs (miRNAs) negatively regulate the stability and translation of target messenger RNAs by selectively binding. It has been implicated in diverse processes such as cellular differentiation, cell-cycle control, apoptosis, and carcinogenesis. Examination of tumor-specific miRNA expression profiles has revealed wide spread dysregulation of these molecules in diverse cancers. The available genomic bulk evidences were extracted from The Cancer Genome Atlas by using IluminaGA_miRNASeq platform in human breast cancer samples. After mining collected data, group of each miRNA ID was analyzed through five D/Bs (mirWalk, miranda, mirDB, RNA22, and TargetScan) on predicted and validated miRNA targets. Oncogenes known to have a high correlation with breast cancer (C-myc, HER2, cyclin D-1, N-RAS, FGF-4, FGF-3, BRCA1, and BRCA2) are subject in this study to select their relevant miRNAs. Function of miRNA regulation will be essential to achieve a complete understanding of carcinogenesis and these miRNAs would be potential target for breast cancer prevention.
引用
收藏
页码:143 / 151
页数:9
相关论文
共 50 条
  • [41] The tissue transglutaminase: a potential target regulating MDR in breast cancer
    Cheng, K.
    Wang, X-H
    Hua, Y-T
    Zhang, Y-Z
    Han, Y.
    Yang, Z-L
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2020, 24 (11) : 6175 - 6184
  • [42] Lipocalin 2: a potential therapeutic target for breast cancer metastasis
    Hu, Chenxia
    Yang, Ke
    Li, Mengjie
    Huang, Weiping
    Zhang, Fengxue
    Wang, Hongqi
    ONCOTARGETS AND THERAPY, 2018, 11 : 8099 - 8106
  • [43] RORα, a Potential Tumor Suppressor and Therapeutic Target of Breast Cancer
    Du, Jun
    Xu, Ren
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2012, 13 (12) : 15755 - 15766
  • [44] The potential of Beclin 1 as a therapeutic target for the treatment of breast cancer
    Jung, Yoon Yang
    Lee, Yu Kyung
    Koo, Ja Seung
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2016, 20 (02) : 167 - 178
  • [45] Tau and stathmin proteins in breast cancer: A potential therapeutic target
    Yang, Hanzhao
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2022, 49 (04) : 445 - 452
  • [46] CXCL3 is a Potential Target for Breast Cancer Metastasis
    See, Amanda Lay Pin
    Chong, Poh Kuan
    Lu, Ssu-Yi
    Lim, Yoon Pin
    CURRENT CANCER DRUG TARGETS, 2014, 14 (03) : 294 - 309
  • [47] Age-related microRNAs in older breast cancer patients: biomarker potential and evolution during adjuvant chemotherapy
    Bruna Dalmasso
    Sigrid Hatse
    Barbara Brouwers
    Annouschka Laenen
    Lieze Berben
    Cindy Kenis
    Ann Smeets
    Patrick Neven
    Patrick Schöffski
    Hans Wildiers
    BMC Cancer, 18
  • [48] MicroRNAs dysregulated in breast cancer preferentially target key oncogenic pathways
    Lim, Weng Khong
    Micklem, Gos
    MOLECULAR BIOSYSTEMS, 2011, 7 (09) : 2571 - 2576
  • [49] Use of potential dietary phytochemicals to target miRNA: Promising option for breast cancer prevention and treatment?
    Abu Sayeed, Md.
    Bracci, Massimo
    Lazzarini, Raffaella
    Tomasetti, Marco
    Amati, Monica
    Lucarini, Guendalina
    Di Primio, Roberto
    Santarelli, Lory
    JOURNAL OF FUNCTIONAL FOODS, 2017, 28 : 177 - 193
  • [50] Field cancerization in mammary carcinogenesis - Implications for prevention and treatment of breast cancer
    Rivenbark, Ashley G.
    Coleman, William B.
    EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2012, 93 (03) : 391 - 398